Clarke Dorothy J 4
4 · Eterna Therapeutics Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Clarke Dorothy J
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-01+168,521→ 168,521 totalExercise: $1.80Exp: 2034-01-01→ Common Stock, par value $0.005 per share (168,521 underlying)
Footnotes (1)
- [F1]Subject to continued service, 25% of the shares underlying the stock option will vest on the nine-month anniversary of the grant date, and the remaining shares underlying the stock option will vest in 39 substantially equal monthly installments thereafter.